26-27 Jan | FREE virtual study fair | REGISTER NOW 26-27 Jan | FREE virtual study fair | REGISTER NOW
University College London Featured PhD Programmes
Heriot-Watt University Featured PhD Programmes
University of Edinburgh Featured PhD Programmes

cancer studies PhD Projects, Programs & Scholarships

We have 154 cancer studies PhD Projects, Programs & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 154 cancer studies PhD Projects, Programs & Scholarships

PhD saved successfully

How do bacteria contribute to aggressive prostate cancer? – A joint lab/bioinformatics PhD studentship

Prostate cancer (PCa) is the second most common cancer in men worldwide and ~307,000 men die every year. We know that infectious agents, such as bacteria and viruses, are involved in the development of a variety of cancers such as cervical, stomach, and bladder cancer. Read more

Networks of support for people affected by a rare cancer: explicating the online communication needs of patients and families

47% of cancer diagnoses in Europe are classified as ‘less common or rare’ (Public Health England, 2014). A rare cancer is a reportedly lonely diagnosis due to lengthy and complex care pathways which can be a barrier to meeting other patients and families. Read more

China Scholarship Council scheme: Contrast-agent free functional lung image-guided therapy: development, validation and application

Lung cancer is the leading cause of cancer deaths and most common cancer worldwide. Although surgery remains the standard of care for early stage lung cancer, the majority of patients suffer impaired lung function due to other, co-existing, pulmonary co-morbidities and thus are inoperable. Read more

Contrast-agent free functional lung image-guided therapy: development, validation and application

Lung cancer is the leading cause of cancer deaths and most common cancer worldwide. Although surgery remains the standard of care for early stage lung cancer, the majority of patients suffer impaired lung function due to other, co-existing, pulmonary co-morbidities and thus are inoperable. Read more
Last chance to apply

Analysing cancer networks evolution using graph neural networks

  Research Group: Institute of Quantitative Biology, Biochemistry and Biotechnology
**PLEASE NOTE – the deadline for requesting a funding pack from Darwin Trust has now passed and completed funding applications must be submitted to Darwin Trust by 19th January. Read more

Cancer: Developing 3D multicellular tumour spheroid models to assess EPA-oncolytic viruses combination therapies in vitro

Cancer immunotherapy holds significant promise for the treatment of a range of cancers. Immunotherapy efficacy, such therapeutic antibodies and oncolytic viruses (OVs), have been clinically assessed against a range of solid tumours. Read more

Cancer: Repurposing drugs as new treatments for breast cancer

Breast cancer (BC) is the most common cancer, with over 1 million new cases diagnosed worldwide each year. For some types of BC, hormonal treatments have been very effective but one particular BC subtype, triple negative breast cancer (TNBC), is highly aggressive and lacks a targeted therapy. Read more

Cancer: Inhibiting cell metabolism to enhance tumour cell death

All the cells in our bodies are programmed to die. As they get older, our cells accumulate toxic molecules that make them sick. In response, they eventually break down and die, clearing the way for new, healthy cells to grow. Read more

Metabolic reprogramming in cancer: starving tumors of essential nutrients to promote cell death

All the cells in our bodies are programmed to die. As they get older, our cells accumulate toxic molecules that make them sick. In response, they eventually break down and die, clearing the way for new, healthy cells to grow. Read more

Targeting steroid metabolism to block colorectal cancer proliferation

Our group is a world leader in targeting specific aspects of steroid metabolism to block cancer growth. Our research has been instrumental in the successful pre-clinical and clinical development of various novel anti-cancer compounds. Read more

Self Funded PhD project: Biological Evaluation of Ruthenium (II) complexes Targeted against Breast Cancers (BRUT BC)

MCF-7 cells are primary tumour invasive breast ductal carcinoma which have both oestrogen and progesterone receptors. Tumour necrosis factor alpha (TNF alpha) inhibits the growth of MCF-7 breast cancer cells. Read more

Filtering Results